NextTrip, Inc. — Capital/Financing Update 2020

Aug 28, 2020

8-K 1 form8-k.htm

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Field: Rule-Page

Field: /Rule-Page

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): August 25, 2020

SIGMA LABS, INC.

(Exact name of registrant as specified in its charter)

Nevada	001-38015	27-1865814
(State
or other jurisdiction of incorporation or organization)	(Commission File Number)	(I.R.S.
Employer Identification No.)

3900 Paseo del Sol

Santa Fe, New Mexico 87507

Field: Rule-Page

Field: /Rule-Page

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (505) 438-2576

Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

| [ ] | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| --- | --- |
| [ ] | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Securities registered pursuant to Section 12(b) of the Act:

| Title
of each class | Trading
Symbol(s) | Name
of each exchange on which registered |
| --- | --- | --- |
| Common
Stock, par value $0.001 per share | SGLB | The
NASDAQ Stock Market LLC |
| Warrants
to Purchase Common Stock, par value $0.001 per share | SGLBW | The
NASDAQ Stock Market LLC |

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

Item 8.01 Other Events.

On August 25, 2020, warrants (the “Preferred Warrants”) to purchase an aggregate of 3,568 shares of Series D Convertible Preferred Stock (the “Preferred Shares”) of Sigma Labs, Inc. (the “Company”) were exercised by four accredited investors, resulting in gross proceeds to the Company of $3,478,800. In connection with the exercise of the Preferred Warrants and the subsequent conversion of Preferred Shares, the Company issued an aggregate of 1,895,049 shares of the Company’s common stock. Following such exercise, 392 Preferred Warrants remain outstanding out of a total of 6,156 Preferred Warrants initially issued.

Field: Page; Sequence: 2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| Date:
August 28, 2020 | |
| --- | --- |
| By: | /s/
Mark K. Ruport |
| Name: | Mark
K. Ruport |
| Title: | President
and Chief Executive Officer |

Field: Page; Sequence: 3; Options: Last

Field: /Page